简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-12-04 17:59 Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea
2015-12-04 16:18 Allied World Announces Enhanced Coverage Options for Healthcare Organizations
2015-12-03 10:39 Boehringer Ingelheim and MD Anderson Cancer Center join forces to discover new treatment approaches for pancreatic cancer
2015-12-02 14:07 The Asian Acne Board and Galderma Join Forces to Improve Understanding and Management of Acne
2015-12-01 13:09 Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
2015-12-01 09:19 Lung cancer experts call for improved EGFR mutation testing to allow all eligible NSCLC patients access to personalised treatment
2015-11-26 17:49 Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)
2015-11-24 10:01 ADDING MULTIMEDIA U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma
2015-11-24 09:11 Pfizer and Allergan to Combine
2015-11-23 13:46 New Survey Showed GI Health and Anti-Aging Benefits of Morinaga's Probiotics Milk with BB536
2015-11-23 11:27 Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept Biosimilar in the European Union
2015-11-19 10:26 Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI® (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
2015-11-19 10:18 Merck and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
2015-11-18 14:44 India’s Leading Maternity and Birthing Care Hospital Group, Cloudnine, Adopts Masimo SET® Technology to Screen Infants for CCHD
2015-11-18 14:30 Pharco Pharmaceuticals Inc. Reports Ravidasvir Achieved 100% Cure Rate to Date When Combined with Sofosbuvir for HCV, Non-Cirrhotic, Genotype 4 Patients
2015-11-18 09:42 GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide
2015-11-18 09:25 Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance
2015-11-17 15:16 Time is of the Essence for Millions Living with ‘Neglected’ Lung Disease: Your Time Campaign Calls for Earlier Action in COPD
2015-11-17 10:13 Replicor Discloses Continued Improvement of the Antiviral Response in Patients with HBV / HDV Co-Infection Receiving REP 2139-Ca Based Combination Therapy
2015-11-16 09:54 New Analyses Further Add to the Efficacy and Safety Profile of OFEV® (nintedanib) in Idiopathic Pulmonary Fibrosis (IPF)

Business Wire Weibo

Press Releases

Latest Releases